SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-144445

Patient #035

Tan Mei Ling · 55y · Female · Chinese · BMI 21.2 · ECOG 0
SMC - Sunway Medical Centre · Cardiothoracic Surgery · Dr. Rajesh Kumar
IIA (T2b, N0)Stable
EGFR L858RPIK3CA
Clinical storyline

Tan Mei Ling, a 55-year-old Chinese female (never, ECOG 0), presented in 2024-07 with incidental finding on routine health screening cxr. Workup confirmed Adenocarcinoma (Stage II, EGFR L858R). The MDT recommended curative-intent surgery. Current status: Stable.

HPE Results
Moderately differentiated primary adenocarcinoma, acinar
Clinical Stage
IIA (T2b, N0)
Pathological Stage
IIA (T2b, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
1.8
Tumor (CT/PET)
4.6 cm
PET SUV
8.68
NGS Results
1. EGFR Exon 21 Mutation (L858R)
2. PIK3CA mutation